RNA
Atrium Therapeutics
$8.40
+$0.08 (+0.96%)Oct 28, 2026
Key metrics
The numbers that frame RNA today
- Market cap
- $143.69M
- Div yield
- 0%
- Debt / equity
- 0.0
Growth
Revenue and earnings trend for RNA
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about RNA
What is the market capitalization of RNA?
Atrium Therapeutics's market capitalization is $143.69M.
Does RNA stock pay dividends?
Atrium Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for RNA?
Atrium Therapeutics's Debt / Equity ratio is 0.01.